MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-DL-10-0004328
Seagull Pharmaceuticals Pvt Ltd - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹113.36 Cr
▲ 8% YoY
Net profit · FY 2025
₹16.99 Cr
Net margin 15%
EBITDA · FY 2025
₹23.21 Cr
EBITDA margin 20.5%
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹2.89 Cr
Issued & subscribed
Satisfied charges
₹2.8 Cr
No open charges
Company age
42 yrs
Est. 1984
Employees · EPFO
453
Provident fund records
About Seagull Pharmaceuticals Pvt Ltd
Data last updated:
Seagull Pharmaceuticals Pvt Ltd is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 November 1984 and has been in existence for over 42 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1984PTC019357. Its GSTIN is 07AAACS2503D1Z0 (Delhi). The company holds 4 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹2.89 Cr. It is led by directors including Subhash Malhotra and Rishabh Singhal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 305 – 306 Imperial Tower C Block Community Centre, New Delhi, Delhi, India – 110028.
As per the financials filed for FY 2025, the company reported a revenue of ₹113.36 Cr, a growth of 8% compared to the previous year. For the same year it recorded a net profit of ₹16.99 Cr (net margin 15%) and EBITDA of ₹23.21 Cr (EBITDA margin 20.5%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 14% over five years.
The company has about 453 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Seagull Pharma. As per MCA filings, the company has satisfied charges of ₹2.8 Cr on record. Court records list 9 cases involving the company, including 5 filed by the company and 4 filed against it; 2 cases are pending. The company has 8 deals on record (5 secondary share transfers, 3 funding rounds), with disclosed funding of ₹22.6 Lakh; the latest was in March 2024. Its 9 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 5 smaller; the largest is Biogenetic Drugs Private Limited with revenue of ₹115.34 Cr. The company has 7 MSME Form 1 returns on record between 2019 and 2023, listing 101 overdue payments to 24 micro and small suppliers.
Seagull Pharmaceuticals Pvt Ltd is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-10-0004328). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website seagullpharma.com.
Company details
CIN U74899DL1984PTC019357
Registration Number 019357
Incorporation Date 21 November 1984
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-DL-10-0004328
Recognitions & Rankings of Seagull Pharmaceuticals
Contact details
Seagull Pharmaceuticals Pvt Ltd's registered office is in New Delhi, Delhi. Its website is seagullpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address305 – 306 Imperial Tower C Block Community Centre, New Delhi, Delhi, India – 110028
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Seagull Pharmaceuticals Pvt Ltd, buy the company report.
Comprehensive company report
Seagull Pharmaceuticals Pvt Ltd - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Seagull Pharmaceuticals operates one associated brand: Seagull Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical company focused on therapeutic drugs and health supplements in India. | seagullpharma.com |
Business activity
The main business activity of Seagull Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Seagull Pharmaceuticals Pvt Ltd, buy the company report.
Financials of Seagull Pharmaceuticals Pvt Ltd
FY 2024 filings availableSeagull Pharmaceuticals Pvt Ltd reported revenue of ₹113.36 Cr (up 8% YoY) for FY 2025.
Revenue · FY 2025
₹113.36 Cr ▲ 8%
Net profit · FY 2025
₹16.99 Cr margin 15%
EBITDA · FY 2025
₹23.21 Cr margin 20.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 8%
3 years · compounded
▲ 9%
5 years · compounded
▲ 14%
EBITDA CAGR growth
1 year
▲ 17%
3 years · compounded
▲ 29%
5 years · compounded
▲ 32%
Revenue has grown at a compounded annual rate (CAGR) of 14% over five years, including 8% growth in the latest year. EBITDA rose 17% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹23.21 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹16.99 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 20.5% | ||||
| Net Profit Margin | 15% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Seagull Pharmaceuticals Pvt Ltd, buy the company report.
Board of directors of Seagull Pharmaceuticals Pvt Ltd
Seagull Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Subhash Malhotra | Director | 01 Apr 1997 | 29 Years 6 Months | Current |
| Rishabh Singhal | Director | 30 Sep 2003 | 23 Years 1 Months | Current |
| Salil Malhotra | Director | 27 Jul 2007 | 19 Years 3 Months | Current |
Peer comparison
Seagull Pharmaceuticals Pvt Ltd is compared with the 9 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Biogenetic Drugs Private Limited | ₹115.34 Cr (FY 2025) | -2.0% | Jaipur, Rajasthan, India | |||
| Synthokem Labs Private Limited | ₹113.98 Cr (FY 2024) | 2.0% | Patancheru, Telangana, India | |||
| Savorite Pharmaceuticals Private Limited | ₹113.71 Cr (FY 2025) | -12.0% | Vadodara, Gujarat, India | |||
| Socomed Pharma Private Limited | ₹113.64 Cr (FY 2025) | -20.0% | Mumbai, Maharashtra, India | |||
| Seagull Pharmaceuticals Pvt Ltdthis company | ₹113.36 Cr (FY 2025) | ₹16.99 Cr | 15% | 8.0% | 453 | New Delhi, Delhi, India |
| Stadmed Pvt Ltd | ₹112.88 Cr (FY 2025) | 0.0% | Kolkata, West Bengal, India | |||
| Shree Ganesh Remedies Limited | ₹112.33 Cr (FY 2025) | -13.0% | Anklesvar, Gujarat, India | |||
| Unicure Remedies Private Limited | ₹112.25 Cr (FY 2025) | -13.0% | Vadodara, Gujarat, India | |||
| Apple Formulations Private Limited. | ₹111.56 Cr (FY 2025) | 3.0% | Delhi, India | |||
| Penang Enterprises Private Limited | ₹111.42 Cr (FY 2025) | 21.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Seagull Pharmaceuticals Pvt Ltd, buy the company report.
Auditor
Seagull Pharmaceuticals Pvt Ltd is audited by K.M. Agarwal & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K.M. Agarwal & Co. | FY 2023 | 000853N |
Shareholding
The shareholding of Seagull Pharmaceuticals Pvt Ltd is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Seagull Pharmaceuticals Pvt Ltd, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹2.8 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 14 Jan 2008 | 10085143 | State Bank of Bikaner & Jaipur | ₹2 Cr | Satisfied | |
| 22 Dec 2003 | 80008269 | State Bank of Bikaner & Jaipur | ₹80 Lakh | Satisfied |
To see the full charge records of Seagull Pharmaceuticals Pvt Ltd, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Seagull Pharmaceuticals Pvt Ltd has 8 deals on record (5 secondary share transfers, 3 funding rounds), with disclosed funding of ₹22.6 Lakh; the latest was in March 2024.
Total deals
8
Secondary share transfers
5
Funding rounds
3
Disclosed funding
₹22.6 Lakh
Deals on record (5 of 8)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2024 | Secondary share transfer | Undisclosed | Seller: 2 individuals |
| May 2023 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Dec 2021 | Secondary share transfer | Undisclosed | Seller: an individual |
| Oct 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Feb 2018 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: 3 individuals |
To see the full deal history of Seagull Pharmaceuticals Pvt Ltd, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Seagull Pharmaceuticals Pvt Ltd has 9 court cases on record: 5 filed by Seagull Pharmaceuticals, 4 filed against it. 2 cases are pending and 7 are disposed.
Total cases
9
Filed by the company
5
Filed against the company
4
Pending
2
Disposed
7
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 5 | 2 | 1 |
| District courts | 3 | 2 | 1 |
| Supreme Court | 1 | 0 | 0 |
Cases on record (5 of 9)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Jharkhand | Court case (Cr.M.P.) | Filed against the company by Cris Pharma (India) Ltd Through Its Authorized Signatory Rajesh Kumar Saini | Pending |
| High Court of Delhi | Commercial suit | Filed by the company against Uni-Pex Pharmaceuticals Pvt. Ltd. & Anr. | Disposed |
| District court, North West, Delhi | Civil suit | Filed by the company against Medi Xpert India Ltd. and 1 other | Disposed |
| District court, Bokaro, Jharkhand | Criminal complaint | Filed against the company | Pending |
| District court, New Delhi, Delhi | Court case (TRAFFIC CHALLAN) | Filed against the company by State | Disposed |
To see the full case history of Seagull Pharmaceuticals Pvt Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Seagull Pharmaceuticals Pvt Ltd has 7 MSME Form 1 returns on record between 2019 and 2023, listing 101 overdue payments to 24 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 24)
To see the full MSME payment records of Seagull Pharmaceuticals Pvt Ltd, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Seagull Pharmaceuticals Pvt Ltd has a workforce of 453 employees on its EPFO records as of Mar 29, 2024, across 1 active EPFO establishment.
Employee count
453
Active EPFO establishments
1
Employee growth
8.37%
GST
Seagull Pharmaceuticals has 4 GST registrations: 4 active.
Total GSTINs
4
Active
4
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACS2503D1Z0 | Delhi | Active | 01 Jul 2017 |
| 08AAACS2503D1ZY | Rajasthan | Active | 01 Jul 2017 |
| 09AAACS2503D1ZW | Uttar Pradesh | Active | 01 Jul 2017 |
| 03AAACS2503D1Z8 | Punjab | Active | 25 Jan 2023 |
To see the full GST registrations and return filing status of Seagull Pharmaceuticals Pvt Ltd, buy the company report.
Recent activity
Seagull Pharmaceuticals Pvt Ltd has 5 board changes on record since 1997: 3 appointments and 2 cessations. The latest: Subhash Malhotra ceased to be Managing Director on 11 May 2023.
AGM
Seagull Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Seagull Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Ceased
Subhash Malhotra ceased to be Managing Director.
Charges
A charge registered on 14 Jan 2008 via Charge ID 10085143 with State Bank Of Bikaner & Jaipur was fully satisfied on 15 Nov 2021.
Ceased
Ajay Bansal ceased to be Additional Director.
Charges
A charge with State Bank Of Bikaner & Jaipur of Rs. 2.00 Cr registered on 14 Jan 2008 with Charge ID 10085143 was modified on 11 May 2012.
Charges
A charge registered on 22 Dec 2003 via Charge ID 80008269 with State Bank Of Bikaner & Jaipur was fully satisfied on 02 Feb 2008.
Charges
A charge with State Bank Of Bikaner & Jaipur amounted to Rs. 2.00 Cr with Charge ID 10085143 was registered on 14 Jan 2008.
Appointed
Salil Malhotra was appointed as Director.
Charges
A charge with State Bank Of Bikaner & Jaipur of Rs. 0.80 Cr registered on 22 Dec 2003 with Charge ID 80008269 was modified on 10 Jul 2006.
Charges
A charge with State Bank Of Bikaner & Jaipur amounted to Rs. 0.80 Cr with Charge ID 80008269 was registered on 22 Dec 2003.
Appointed
Rishabh Singhal was appointed as Director.
2 earlier events are in the company report.
Frequently asked questions
Seagull Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 November 1984 (42+ years old) and is registered under CIN U74899DL1984PTC019357.
Seagull Pharmaceuticals has 3 current directors:
- Subhash Malhotra - Director
- Rishabh Singhal - Director
- Salil Malhotra - Director
The latest financial statements of Seagull Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Seagull Pharmaceuticals is 07AAACS2503D1Z0, registered in Delhi. The company has 4 GST registrations in all, of which 4 are active. Other active GSTINs include 08AAACS2503D1ZY (Rajasthan), 09AAACS2503D1ZW (Uttar Pradesh), 03AAACS2503D1Z8 (Punjab).
The CIN (Corporate Identification Number) of Seagull Pharmaceuticals is U74899DL1984PTC019357. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Seagull Pharmaceuticals has 9 court cases on record: 5 filed by the company and 4 filed against it. 2 are pending. Most are in the high courts.
Seagull Pharmaceuticals was incorporated on 21 November 1984, making it 42+ years old. It is registered with the Registrar of Companies, Delhi.
Seagull Pharmaceuticals has 8 deals on record (5 secondary share transfers, 3 funding rounds), with disclosed funding of ₹22.6 Lakh; the latest was in March 2024.
The peers of Seagull Pharmaceuticals by revenue are Biogenetic Drugs Private Limited, Synthokem Labs Private Limited, Savorite Pharmaceuticals Private Limited, Socomed Pharma Private Limited, Stadmed Pvt Ltd and 4 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Subhash Malhotra ceased to be Managing Director on 11 May 2023. Ajay Bansal ceased to be Additional Director on 30 Jun 2020. Salil Malhotra was appointed as Director on 27 Jul 2007. Seagull Pharmaceuticals has 5 board changes on record in total.
Yes, Seagull Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-DL-10-0004328).
Seagull Pharmaceuticals has 7 MSME Form 1 returns on record between 2019 and 2023, listing 101 overdue payments to 24 micro and small suppliers. The latest return was filed on 29 Aug 2023.